Joint Consultation Between a Neurologist and a Clinical Psychologist
JOCONDE
Evaluation of a Joint Consultation Between a Neurologist and a Clinical Psychologist, Dedicated to Neurodegenerative and/or Neurogenetic Disorders
1 other identifier
observational
200
1 country
1
Brief Summary
Joint consultations appeared a few years ago in routine medical practice, but they are still not widely used and rarely evaluated. The primary purpose of the study is to evaluate the impact for the patient of the presence of a clinical psychologist during the joint consultation. The secondary purpose is to evaluate the impact for the patient and for the neurologist of the presence of a clinical psychologist during the joint consultation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
May 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedJune 13, 2022
May 1, 2022
2 years
May 23, 2022
June 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient satisfaction after the consultation assessed by 3 questions on a Likert scale
5-point Likert scale from which to select a response : 1. Very satisfied. 2. Moderately satisfied. 3. Neither satisfied nor dissatisfied. 4. Moderately dissatisfied. 5. Very dissatisfied.
After consultation et 1 to 3 months later
Eligibility Criteria
Adult patient with a neurodegenerative and/or neurogenetic disease
You may qualify if:
- patient with a neurodegenerative and/or neurogenetic disease
- adult patient
You may not qualify if:
- dementia
- age \<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Neurologie - CHU de Strasbourg - France
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathieu ANHEIM, MD, PhD
Service de Neurologie - CHU de Strasbourg - France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
May 27, 2022
Study Start
June 1, 2021
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
June 13, 2022
Record last verified: 2022-05